BOSUTINIB Sandoz cpr pell 400 mg 28 pce
7680691450020
CH-69145
L01EA04
07.16.1.
Reimbursement limitations:
BOSUTINIBSAN
Bosutinib Sandoz est indiqué pour le traitement des patients adultes atteints de leucémie myéloïde chronique …
1 / 3
google
Details
- Product number
- 6914502
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- bosutinibum 400 mg ut bosutinibum dihydricum, cellulosum microcristallinum, crospovidonum, poloxamerum 188, povidonum K 25, magnesii stearas, hypromellosum, E 171, macrogolum 6000, E 172 (flavum), E 172 (rubrum), pro compresso obducto.
Articles (1)
Bosutinib Sandoz 400 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 1473.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2025
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69145
- Drug name
- Bosutinib Sandoz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/06/2024
- Authorization expiration date
- 03/06/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BOSUTINIB Sandoz cpr pell 400 mg 28 pce
- Description (DE)
- BOSUTINIB Sandoz Filmtabl 400 mg 28 Stk
- Market launch
- 04/06/2024
- Narcotic (BTM)
- No